These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2169974)

  • 41. Loss of heterozygosity on chromosomal segments 3p, 6q and 11p in human ovarian carcinomas.
    Ehlen T; Dubeau L
    Oncogene; 1990 Feb; 5(2):219-23. PubMed ID: 2320374
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].
    Maestro ML; Izquierdo L; Sánchez-Pernaute A; Sanz Casla MT; González S; Torres A; del Barco V; Gómez A; Pérez Aguirre E; Balibrea JL
    Med Clin (Barc); 1999 Apr; 112(14):527-9. PubMed ID: 10363238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
    Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
    Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Allelic deletion analysis of the FHIT gene predicts poor survival in non-small cell lung cancer.
    Burke L; Khan MA; Freedman AN; Gemma A; Rusin M; Guinee DG; Bennett WP; Caporaso NE; Fleming MV; Travis WD; Colby TV; Trastek V; Pairolero PC; Tazelaar HD; Midthun DE; Liotta LA; Harris CC
    Cancer Res; 1998 Jun; 58(12):2533-6. PubMed ID: 9635574
    [TBL] [Abstract][Full Text] [Related]  

  • 45. LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer.
    Sanz-Ortega J; Bryant B; Sanz-Esponera J; Asenjo JA; Saez MC; Torres A; Balibrea JL; Sobel ME; Merino MJ
    Pathol Res Pract; 1999; 195(10):677-80. PubMed ID: 10549031
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Restriction polymorphism of the proto-oncogene c-Ha-ras-1 in patients with multiple primary malignant neoplasms and non-small-cell lung cancer].
    Gaspar'ian AV; Sel'chuk VIu; Iakubovskaia MG; Zborovskaia IB; Tatosian AG
    Genetika; 1997 Jan; 33(1):96-100. PubMed ID: 9162692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Allelic deletion mapping on chromosome 5 in human carcinomas.
    Wieland I; Böhm M; Arden KC; Ammermüller T; Bogatz S; Viars CS; Rajewsky MF
    Oncogene; 1996 Jan; 12(1):97-102. PubMed ID: 8552404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer.
    Marsit CJ; Hasegawa M; Hirao T; Kim DH; Aldape K; Hinds PW; Wiencke JK; Nelson HH; Kelsey KT
    Cancer Res; 2004 Dec; 64(23):8702-7. PubMed ID: 15574780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
    Hurr K; Kemp B; Silver SA; el-Naggar AK
    Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer.
    Naylor SL; Johnson BE; Minna JD; Sakaguchi AY
    Nature; 1987 Oct 1-7; 329(6138):451-4. PubMed ID: 2821400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: comparison with cytogenetic analysis.
    Buchhagen DL; Worsham MJ; Dyke DL; Carey TE
    Head Neck; 1996; 18(6):529-37. PubMed ID: 8902566
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
    Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.
    Hayashi M; Tokuchi Y; Hashimoto T; Hayashi S; Nishida K; Ishikawa Y; Nakagawa K; Tsuchiya S; Okumura S; Tsuchiya E
    Anticancer Res; 2001; 21(1B):535-40. PubMed ID: 11299800
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequent loss of heterozygosity at the retinoblastoma locus in human esophageal cancers.
    Boynton RF; Huang Y; Blount PL; Reid BJ; Raskind WH; Haggitt RC; Newkirk C; Resau JH; Yin J; McDaniel T; Meltzer SJ
    Cancer Res; 1991 Oct; 51(20):5766-9. PubMed ID: 1913694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous-cell carcinoma, large-cell carcinoma, and adenocarcinoma of the human lung.
    Weston A; Willey JC; Modali R; Sugimura H; McDowell EM; Resau J; Light B; Haugen A; Mann DL; Trump BF
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5099-103. PubMed ID: 2567993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromosome alterations in human small cell lung cancer: frequent involvement of 5q.
    Miura I; Graziano SL; Cheng JQ; Doyle LA; Testa JR
    Cancer Res; 1992 Mar; 52(5):1322-8. PubMed ID: 1346589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recessive genetic mechanisms in the oncogenesis of prostatic carcinoma.
    Bergerheim US; Collins VP; Ekman P; Kunimi K
    Scand J Urol Nephrol Suppl; 1991; 138():93-6. PubMed ID: 1686123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular genetic alterations in superficial and locally advanced human bladder cancer.
    Presti JC; Reuter VE; Galan T; Fair WR; Cordon-Cardo C
    Cancer Res; 1991 Oct; 51(19):5405-9. PubMed ID: 1680549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topographical distributions of allelic loss in individual non-small-cell lung cancers.
    Yatabe Y; Konishi H; Mitsudomi T; Nakamura S; Takahashi T
    Am J Pathol; 2000 Sep; 157(3):985-93. PubMed ID: 10980137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.
    Hung J; Kishimoto Y; Sugio K; Virmani A; McIntire DD; Minna JD; Gazdar AF
    JAMA; 1995 Feb; 273(7):558-63. PubMed ID: 7837389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.